Science Explorer Back to mapMap

Most cited papers from Catalysis Foundation for Health

What are the most cited papers from Catalysis Foundation for Health?

The most cited paper from Catalysis Foundation for Health is "Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure" (Stephanus T. Malherbe et al., 2016), with 317 citations. Next come "A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes" (257) and "Host blood RNA signatures predict the outcome of tuberculosis treatment" (198).

Showing 24 of 24 papers. Every paper is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Persisting positron emission tomography lesion activity and Mycobacterium tuberculosis mRNA after tuberculosis cure Stephanus T. Malherbe et al. · Nature Medicine Open access 5 Sep 2016 317
2 A multi-cohort study of the immune factors associated with M. tuberculosis infection outcomes Roshni Roy Chowdhury, Francesco Vallania, Qianting Yang et al. · Nature Open access Aug 2018 257
3 Host blood RNA signatures predict the outcome of tuberculosis treatment Ethan Thompson et al. · Tuberculosis Open access 12 Aug 2017 198
4 RISK6, a 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response Adam Penn‐Nicholson et al. · Scientific Reports Open access269 authors 25 May 2020 177
5 Assessment of Validity of a Blood-Based 3-Gene Signature Score for Progression and Diagnosis of Tuberculosis, Disease Severity, and Treatment Response Hayley Warsinske, Aditya Rao, Flora Martinez Figueira Moreira et al. · JAMA Network Open Open access 26 Oct 2018 151
6 Diagnostic Accuracy of the Cepheid 3-gene Host Response Fingerstick Blood Test in a Prospective, Multi-site Study: Interim Results Jayne S. Sutherland et al. · Clinical Infectious Diseases Open access 17 Sep 2021 116
7 Quantitative 18F-FDG PET-CT scan characteristics correlate with tuberculosis treatment response Stephanus T. Malherbe et al. · EJNMMI Research Open access 10 Feb 2020 57
8 Exploring Alternative Biomaterials for Diagnosis of Pulmonary Tuberculosis in HIV-Negative Patients by Use of the GeneXpert MTB/RIF Assay Shubhada Shenai, Danielle Amisano, Katharina Ronacher et al. · Journal of Clinical Microbiology Open access 10 Oct 2013 57
9 Fourteen-day PET/CT imaging to monitor drug combination activity in treated individuals with tuberculosis Yingda L. Xie et al. · Science Translational Medicine Open access 3 Feb 2021 48
10 Using biomarkers to predict TB treatment duration (Predict TB): a prospective, randomized, noninferiority, treatment shortening clinical trial Ray Y. Chen et al. · Gates Open Research Open access 6 Nov 2017 45
11 Bacterial Loads Measured by the Xpert MTB/RIF Assay as Markers of Culture Conversion and Bacteriological Cure in Pulmonary TB Shubhada Shenai, Katharina Ronacher, Stefanus Malherbe et al. · PLoS ONE Open access 10 Aug 2016 45
12 Investigating Non-sterilizing Cure in TB Patients at the End of Successful Anti-TB Therapy Caroline G. G. Beltran, Tiaan D. J. Heunis, James Gallant et al. · Frontiers in Cellular and Infection Microbiology Open access 25 Aug 2020 33
13 A semi-automatic technique to quantify complex tuberculous lung lesions on 18F-fluorodeoxyglucose positron emission tomography/computerised tomography images Stephanus T. Malherbe, Patrick J. Dupont, Ilse M.J. Kant et al. · EJNMMI Research Open access 25 Jun 2018 25
14 Neutrophil degranulation, NETosis and platelet degranulation pathway genes are co-induced in whole blood up to six months before tuberculosis diagnosis Stuart Meier, James A. Seddon, Elizna Maasdorp et al. · PLoS ONE Open access Dec 2022 16
15 Field evaluation of a point-of-care triage test for active tuberculosis (TriageTB) Tracy Richardson et al. · BMC Infectious Diseases Open access 3 Jul 2023 14
16 RISK6, a universal 6-gene transcriptomic signature of TB disease risk, diagnosis and treatment response Adam Penn‐Nicholson et al. · medRxiv PreprintOpen access 9 Sep 2019 14
17 The Peripheral Blood Transcriptome Is Correlated With PET Measures of Lung Inflammation During Successful Tuberculosis Treatment Trust Odia, Stephanus T. Malherbe, Stuart Meier et al. · Frontiers in Immunology Open access 10 Feb 2021 13
18 Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy Bryna L. Fitzgerald, M. Nurul Islam, Barbara Graham et al. · ACS Infectious Diseases Open access 26 Dec 2018 13
19 PET/CT guided tuberculosis treatment shortening: a randomized trial Stephanus T. Malherbe et al. · medRxiv PreprintOpen access 4 Oct 2024 11
20 Performance of 2 Finger-Stick Blood Tests to Triage Adults With Symptoms of Pulmonary Tuberculosis: A Prospective Multisite Diagnostic Accuracy Study Jayne S. Sutherland et al. · Clinical Infectious Diseases Open access114 authors 7 Mar 2025 7
21 Clinical testing of drug treatment shortening in patients with TB using PET/CT imaging of lung lesions Stephanus T. Malherbe et al. · Science Translational Medicine Open access 7 Jan 2026 5
22 The impact of prior SARS-CoV-2 infection on host inflammatory cytokine profiles in patients with TB or other respiratory diseases Annabelle Cottam, Ismaila L. Manneh, Awa Gindeh et al. · Frontiers in Immunology Open access 21 Dec 2023 3
23 Transcript-Capture sequencing enriches mRNA of Mycobacterium tuberculosis from host samples Eleanor I. Lamont, Richard M Jones, Jessica Assadi et al. · NAR Molecular Medicine Open access 24 Dec 2025 2
24 Predicting TB treatment outcomes using baseline risk and treatment response markers: developing the PredictTB early treatment completion criteria Ray Y. Chen, Jing Wang, Lili Liang et al. · Gates Open Research Open access 14 Oct 2020 0

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.